Valeo Pharma Inc VPHIF

Healthcare

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.

GREY:VPHIF - Post by User

Valeo Pharma Inc > financials up on sedar

<< Previous

Bullboard Posts

Next >>

Comment by kooter33on Sep 30, 2020 1:25pm

140 Views

Post# 31642521

RE:financials up on sedar

obviously the market was anticipating a better Q3 than what was presented. BB's were tight and the SP did breakout but to the downside. 50 DMA is significant resistance. CC I hope will help better explain the VPH outcome going forward. They did say that they would be EBITDA positive by the end of Q4. Q4 ends Oct 31st 2020. Lets see what that entails, until then I will accumulate more on weakness. GL.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market